慢性病毒性肝炎

  • 网络chronic viral hepatitis;chronic virus hepatitis;cvh
慢性病毒性肝炎慢性病毒性肝炎
  1. 血清透明质酸对慢性病毒性肝炎肝纤维化诊断价值的系统评价

    The Diagnostic Value of Serum Hyaluronic Acid for Liver Fibrosis in Patients with Chronic Viral Hepatitis : A Systematic Review

  2. 慢性病毒性肝炎患者磁共振~(31)P波谱与病理表现的关系

    The relationship between ~ ( 31 ) P magnetic resonance spectroscopy and the histopathology of livers of chronic viral hepatitis patients

  3. Bcl-2和Bax蛋白在慢性病毒性肝炎肝组织中的表达

    Expression of Bcl-2 and Bax proteins in liver tissues of chronic viral hepatitis

  4. 猪胸腺素(F5)对慢性病毒性肝炎病人免疫功能和血清谷丙酶的影响

    Effect of Porcine Thymosin ( F_5 ) on Immune Function and SGPT in Patiens with Chronic Viral Hepatitis

  5. 方法:采用ELISA法检测32例慢性病毒性肝炎患者治疗前后血清抗-IFN。

    Method : Anti-IFN was detected by using ELISA method in the sera from 32 patients with chronic hepatitis .

  6. 慢性病毒性肝炎肝细胞凋亡与Fas抗原和病毒表达的相互关系

    Hepatocyte apoptosis in chronic viral hepatitis and its relationship with viral and Fas antigen expression

  7. 结果慢性病毒性肝炎及肝硬化患者血清IL-8均明显高于正常对照组(P<0.001和P<0.01)。

    Results Comparing with control , the IL - 8 level in patients with chronic viral hepatitis or cirrhosis was increased ( P < 0.001 or P < 0.01 , respectively ) .

  8. 补肾冲剂治疗慢性病毒性肝炎AFP持续低浓度阳性

    Clinical Research on Bushen Granule in Treating Chronic Virus Hepatitis with Positive AFP of Steady Low Concentration

  9. HBV的感染不仅能够引起急、慢性病毒性肝炎,而且部分感染者会发生肝硬化和肝细胞癌。

    In addition to causing acute hepatitis or chronic hepatitis , HBV often eventually lead to cirrhosis and hepatocellular carcinoma in some patient .

  10. 采用抗病毒生物中和测定法检测321例IFNα治疗的慢性病毒性肝炎患者中的NA。

    METHODS : NA was assayed by antiviral neutralizing bioassay in 321 chronic viral hepatitis patients treated with recombinant interferon alpha .

  11. 慢性病毒性肝炎病人Tac蛋白变化及其意义探讨

    Changes of TAC protein in patients with chronic viral hepatitis and their significance

  12. 慢性病毒性肝炎患者血清IGF-Ⅰ、TNF-α及SS测定的临床意义

    Clinical Significance of Determination of Serum IGF - ⅰ, TNF - α and SS Levels in Patients with Chronic Viral Hepatitis

  13. 目的探讨慢性病毒性肝炎患者中α干扰素(αIFN)中和抗体(NA)的产生及其对干扰素疗效的影响。

    Objective To study the influence of interferon alpha ( IFN α) neutralizing antibody ( NA ) on the therapeutic effectiveness of IFN α .

  14. 小儿哮喘病与BMI的相关性研究慢性病毒性肝炎不同分级分期方法的探讨

    The Relationship Between Asthma and Obesity in Children A comparative study in different grading and staging classification of chronic hepatitis B

  15. 慢性病毒性肝炎患者抗病毒治疗前后血清IL-10、IL-12水平变化及意义

    Detection of IL-10 , IL-12 level in sera of patients with chronic hepatitis B before and after antiviral treatment

  16. 目的:观察补肾冲剂对慢性病毒性肝炎甲胎蛋白(AFP)持续低浓度阳性的影响。

    Objective : To observe the effect of Bushen granule on the chronic virus hepatitis with positive AFP of steady low concentration .

  17. 乙型慢性病毒性肝炎存在着不同程度的免疫功能失调,尤其是细胞免疫功能失调的情况,经临床观察发现具有培本补虚作用的冬虫夏草能升高CD4+、NK细胞,提高CD4+/CD8+比值。

    Patients of chronic hepatitis B exist immunological disorders disturbances of immune function in various degrees , especially disturbances of cellular immunity function .

  18. 目的:观察慢性病毒性肝炎患者应用大剂量干扰素治疗前后白细胞介素-10(IL-10)、白细胞介素-12(IL-12)水平变化及意义。

    Objective : To observe IL10 , IL12 level changes in sera of patients with hepatitis B treated by interferon .

  19. 对30例慢性病毒性肝炎分别检测了抗-RVIgM、HBV血清学标志物、抗-HCV抗体及生化指标;

    Sera from 32 cases with chronic viral hepatitis were defected for RV IgM antibodies , HCV antibodies , sera sign of HBV and biochemical perameters .

  20. 前列腺素E1治疗慢性病毒性肝炎、肝硬化及重症肝炎的疗效

    Clinical observation on the effects of prostaglandin El in patients with chronic viral hepatitis , hepatic cirrhosis and severe hepatitis

  21. 慢性病毒性肝炎患者红细胞CR1粘附活性的变化

    Changes of activity of CR1 expressed on erythrocyte in patients with chronic viral hepatitis

  22. 乙肝病毒标志阴性慢性病毒性肝炎患者HBV-DNA及肝组织中HBsAg、HBcAg检测的临床意义

    Clinical Significance of Serum HBV-DNA and Liver Tissues HBsAg and HBcAg Assay in Chronic Hepatitis Patients with Negative Hepatitis B Virus Marks

  23. 外周血单核细胞CD83表达在慢性病毒性肝炎中意义的初步研究

    Significance of CD83 expression in peripheral blood monocytes in patients with chronic hepatitis B

  24. 为探讨重组α干扰素(IFNα)治疗慢性病毒性肝炎时,IFNα中和抗体(NA)的产生和影响。

    To study the production and clinical significance of interferon alpha ( IFN α) neutralizing antibodies ( NA ) in patients with chronic viral hepatitis treated with recombinant interferon alpha .

  25. OA是治疗急性黄胆型肝炎和慢性病毒性肝炎比较理想的药物,且毒性低,不良反应少。

    Oleanolic acid is a perfect drug to treat acute icterohepatitis and chronic viral hepatitis , and it is in the nature of low toxicity and fewer side effects .

  26. 结论DWI技术能评价活体慢性病毒性肝炎的活动度和纤维化程度。

    Conclusion DWI is a valuable method for in vivo and non-invasive assessment of the disease activity and liver fibrosis of chronic viral hepatitis .

  27. 乙型肝炎病毒(HBV)感染,不仅引起急、慢性病毒性肝炎,而且是肝纤维化和肝细胞癌(Hepatocellularcarcinoma,HCC)的主要病因。

    Hepatitis B virus ( HBV ) infection causes acute and chronic viral hepatitis , which is also considered to be a major etiological factor in the development of liver cirrhosis and hepatocellular carcinoma ( HCC ) .

  28. 慢性病毒性肝炎(Chronicviralhepatitis,CVH)是由多种肝炎病毒引起的,以肝脏炎症和坏死病变为主的一组传染病。

    Chronic viral hepatitis ( CVH ) is caused by a variety of hepatitis virus , with liver inflammation and necrosis of the pathological changes is given priority to a group of infectious diseases .

  29. 结果:慢性病毒性肝炎PBMC中TGF-β1mRNA和IFN-γmRNA均高于正常(P0.05)。

    Results : Trie patients with chronic viral hepatitis had significantly higher PBMC TGF-p1 mRNA levels and PBMC IFN-r mRNA levels than those in normal subjects ( P 0.05 ) .

  30. 采用随机、对照临床试验方法观察硫普罗宁片剂对108例慢性病毒性肝炎患者的疗效。治疗组应用硫普罗宁片剂,po,100mg/次,tid。

    The efficacy of tiopronin tablets in treatment of chronic viral hepatitis were conducted in 108 patients in a dose of 100 mg tid for 12 weeks .